Table 1 Demographics and baseline characteristics
Characteristics | Total Cohort (n = 18) | Low-dose group (n = 6) | Mid-dose group (n = 6) | High-dose group (n = 6) |
|---|---|---|---|---|
Age (Median/range, years) | 37 (27-64) | 36 (27-64) | 40 (32-62) | 39 (27-55) |
Gender | ||||
Male | 12 | 4 | 4 | 4 |
Female | 6 | 2 | 2 | 2 |
Smoker (n) | 2 | 2 | 0 | 0 |
Height (Mean ± SD, cm) | 166.39 ± 8.81 | 166.33 ± 10.52 | 166.83 ± 5.85 | 166.00 ± 10.88 |
Weight (Mean ± SD, kg) | 65.78 ± 13.52 | 68.92 ± 16.72 | 64.08 ± 10.62 | 64.33 ± 14.53 |
BMI (Mean ± SD, kg/m2) | 23.64 ± 3.75 | 24.68 ± 1.14 | 22.91 ± 2.65 | 23.32 ± 4.65 |
Months since symptom onset (Median/range) | 21 (6-120) | 26 (6-72) | 30 (6-120) | 21 (12-96) |
Knee laterality | ||||
Left | 8 | 5 | 2 | 1 |
Right | 10 | 1 | 4 | 5 |
MRI of injected kneea | ||||
I degree | 2 | 0 | 1 | 1 |
II degree | 16 | 6 | 5 | 5 |
Coexisting diseases (n) | 4 | 0 | 3 | 1 |
Gout | 2 | 0 | 2 | 0 |
Heart disease | 1 | 0 | 0 | 1 |
Alimentary disease | 1 | 0 | 1 | 0 |
